v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (61,002,954) $ (5,713,369)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 8,327 664
Change in fair value of SAFE notes 39,834,049 1,631,446
Stock-based compensation 8,424,803 1,171,287
Changes in operating assets and liabilities:    
Prepaid expenses (902,448) (32,113)
Accounts payable 443,473 75,803
Accrued expenses 153,387 31,777
Accrued compensation (9,832) 34,863
Net cash used in operating activities (13,051,195) (2,799,642)
Cash flows from investing activities:    
Purchases of property and equipment (43,436) (2,657)
Net cash used in investing activities (43,436) (2,657)
Cash flows from financing activities:    
Proceeds from exercise of restricted stock awards 1,098 5,392
Proceeds from SAFE notes 2,993,800 8,590,000
Proceeds from private placement 30,000,000  
Offering costs paid (2,909,740)  
Payment of related party loan   (10,000)
Net cash provided by financing activities 30,085,158 8,585,392
Net increase in cash and cash equivalents 16,990,527 5,783,093
Cash and cash equivalents, beginning of the year 6,728,895 945,802
Cash and cash equivalents, end of the year 23,719,422 6,728,895
Supplemental cash flow information:    
Subscription of SAFE notes   $ 110,000
Conversion of SAFE Notes into common stock $ 53,511,234